Literature DB >> 1654561

A first-order reaction controls the binding of antigenic peptides to major histocompatibility complex class II molecules.

S N Witt1, H M McConnell.   

Abstract

Major histocompatibility complex class II molecules have been reported to bind antigenic peptides very slowly in vitro. To investigate the molecular events that govern the slow binding reaction, we have determined the dependence of complex formation and dissociation on peptide concentration. The complex between the purified major histocompatibility complex class II protein I-Ek and a fluoresceinated peptide representing amino acids 89-104 of pigeon cytochrome c (FpCytc) was studied. Two important results emerge from this study. (i) At pH 5.4, the half-time for I-Ek-FpCytc complex formation is equal to approximately 7 hr for peptide concentrations that vary over a range of three orders of magnitude. There is in fact a small but significant decrease in the half-time for complex formation at low peptide concentrations. The small decrease in half-time is related to the release of endogenous peptides. (ii) At large ratios of peptide to protein [( FpCytc]/[I-Ek] greater than 40), the half-times for I-Ek-FpCytc complex formation and dissociation are equal to one another to within a factor of two between pH 7.5 and 4.5. The percent results demonstrate that a slow, first-order reaction precedes complex formation between I-Ek and FpCytc. This first-order reaction may involve a protein conformational change in addition to the release of endogenous peptides.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1654561      PMCID: PMC52467          DOI: 10.1073/pnas.88.18.8164

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  21 in total

1.  High-affinity binding of an influenza hemagglutinin-derived peptide to purified HLA-DR.

Authors:  P A Roche; P Cresswell
Journal:  J Immunol       Date:  1990-03-01       Impact factor: 5.422

2.  Refolding and reassembly of separate alpha and beta chains of class II molecules of the major histocompatibility complex leads to increased peptide-binding capacity.

Authors:  K Dornmair; H M McConnell
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

3.  The CH series of murine B cell lymphomas: neoplastic analogues of Ly-1+ normal B cells.

Authors:  G Haughton; L W Arnold; G A Bishop; T J Mercolino
Journal:  Immunol Rev       Date:  1986-10       Impact factor: 12.988

4.  Isolation and characterization of antigen-Ia complexes involved in T cell recognition.

Authors:  S Buus; A Sette; S M Colon; D M Jenis; H M Grey
Journal:  Cell       Date:  1986-12-26       Impact factor: 41.582

5.  Autologous peptides constitutively occupy the antigen binding site on Ia.

Authors:  S Buus; A Sette; S M Colon; H M Grey
Journal:  Science       Date:  1988-11-18       Impact factor: 47.728

6.  Monoclonal antibodies against the antigen receptor on a cloned T-cell hybrid.

Authors:  L E Samelson; R N Germain; R H Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  1983-11       Impact factor: 11.205

7.  Allogeneic stimulation of cytotoxic T cells by supported planar membranes.

Authors:  A A Brian; H M McConnell
Journal:  Proc Natl Acad Sci U S A       Date:  1984-10       Impact factor: 11.205

8.  Phospholipids enhance the binding of peptides to class II major histocompatibility molecules.

Authors:  R W Roof; I F Luescher; E R Unanue
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

9.  Hybridoma cell lines secreting monoclonal antibodies to mouse H-2 and Ia antigens.

Authors:  K Ozato; N Mayer; D H Sachs
Journal:  J Immunol       Date:  1980-02       Impact factor: 5.422

10.  Regulation of antigen presentation by acidic pH.

Authors:  P E Jensen
Journal:  J Exp Med       Date:  1990-05-01       Impact factor: 14.307

View more
  12 in total

1.  Interpretation of biphasic dissociation kinetics for isomeric class II major histocompatibility complex-peptide complexes.

Authors:  T G Anderson; H M McConnell
Journal:  Biophys J       Date:  1999-11       Impact factor: 4.033

2.  Short-lived complexes between myelin basic protein peptides and IAk.

Authors:  K Mason; H M McConnell
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

3.  Evidence for cobinding of self- and allopeptides to human class II major histocompatibility antigen DR1 by energy transfer.

Authors:  H Kropshofer; H Max; H Kalbacher
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-15       Impact factor: 11.205

4.  Enhancement of peptide antigen presentation by a second peptide.

Authors:  A I de Kroon; H M McConnell
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-01       Impact factor: 11.205

5.  Kinetic intermediates in the reactions between peptides and proteins of major histocompatibility complex class II.

Authors:  C Beeson; H M McConnell
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

6.  Resolving multiple protein-peptide binding events: implication for HLA-DQ2 mediated antigen presentation in celiac disease.

Authors:  Jianhao Wang; Xi Jin; Jiahui Liu; Chaitan Khosla; Jiang Xia
Journal:  Chem Asian J       Date:  2012-03-12

7.  A structural transition in class II major histocompatibility complex proteins at mildly acidic pH.

Authors:  H A Runnels; J C Moore; P E Jensen
Journal:  J Exp Med       Date:  1996-01-01       Impact factor: 14.307

8.  pH dependence and exchange of high and low responder peptides binding to a class II MHC molecule.

Authors:  P A Reay; D A Wettstein; M M Davis
Journal:  EMBO J       Date:  1992-08       Impact factor: 11.598

9.  Evidence that the autoimmune antigen myelin basic protein (MBP) Ac1-9 binds towards one end of the major histocompatibility complex (MHC) cleft.

Authors:  C Lee; M N Liang; K M Tate; J D Rabinowitz; C Beeson; P P Jones; H M McConnell
Journal:  J Exp Med       Date:  1998-05-04       Impact factor: 14.307

10.  Evidence for a conformational change in a class II major histocompatibility complex molecule occurring in the same pH range where antigen binding is enhanced.

Authors:  J J Boniface; D S Lyons; D A Wettstein; N L Allbritton; M M Davis
Journal:  J Exp Med       Date:  1996-01-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.